Fine Mapping of Epitopes for Antibodies to the Juxtamembrane Domain of IA-2 in Type 1 Diabetes

被引:0
|
作者
Johnson, Carolyn C.
Mclaughlin, Kerry A.
Morgan, Diana
Feltbower, Richard G.
Christie, Michael R.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1652-P
引用
收藏
页码:A430 / A430
页数:1
相关论文
共 50 条
  • [31] IA-2 combined epitope assay: A new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes
    Tiberti, C
    Verrienti, A
    Fiore, B
    Yu, LP
    Eisenbarth, GS
    Dotta, F
    Di Mario, U
    CLINICAL IMMUNOLOGY, 2005, 115 (03) : 260 - 267
  • [32] The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype Results from the TODAY study
    Klingensmith, Georgeanna J.
    Pyle, Laura
    Arslanian, Silva
    Copeland, Kenneth C.
    Cuttler, Leona
    Kaufman, Francine
    Laffel, Lori
    Marcovina, Santica
    Tollefsen, Sherida E.
    Weinstock, Ruth S.
    Linder, Barbara
    DIABETES CARE, 2010, 33 (09) : 1970 - 1975
  • [33] Are GAD65 and IA-2 autoantibodies sufficient to predict Type 1 diabetes?
    Pietropaolo, M
    Becker, DJ
    Dorman, JS
    Laporte, RE
    Mazumdar, S
    Rudert, WA
    Trucco, M
    DIABETES, 1999, 48 : A45 - A45
  • [34] Predictive value of autoantibodies to IA-2 for insulin requirement in Japanese type 1 diabetes
    Ota, T
    Takamura, T
    Nagai, Y
    Bando, Y
    Usuda, R
    Kobayashi, K
    DIABETOLOGIA, 2001, 44 : A101 - A101
  • [35] FCLR3 is associated with autoantibodies to IA-2 at diagnosis of Type 1 diabetes
    Fareed, R.
    Ye, J.
    Mortimer, G.
    Chipper-Keating, S.
    Chandler, K.
    Gillespie, K. M.
    Long, A. E.
    Williams, A. J. K.
    DIABETIC MEDICINE, 2017, 34 : 33 - 33
  • [36] Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects
    Nishino, M
    Ikegami, H
    Kawaguchi, Y
    Fujisawa, T
    Kawabata, Y
    Shintani, M
    Ono, M
    Horiki, M
    Kawasaki, E
    Ogihara, T
    HUMAN IMMUNOLOGY, 2001, 62 (05) : 518 - 522
  • [37] Differential splicing of the IA-2 gene in pancreas and lymphoid organs as a predisposing factor to autoimmune responses against the IA-2 molecule in type 1 diabetes
    Diez, J
    Park, Y
    Zeller, M
    Ricordi, C
    Hutton, J
    Eisenbarth, G
    Pugliese, A
    DIABETES, 2000, 49 : A207 - A207
  • [38] Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen
    Diez, J
    Park, Y
    Zeller, M
    Brown, D
    Garza, D
    Ricordi, C
    Hutton, J
    Eisenbarth, GS
    Pugliese, A
    DIABETES, 2001, 50 (04) : 895 - 900
  • [39] Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes
    Urakami, Tatsuhiko
    Yoshida, Ayako
    Suzuki, Junichi
    Saito, Hitoshi
    Wada, Mika
    Takahashi, Shouri
    Mugishima, Hideo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 89 - 93
  • [40] T-Cell Epitopes in Type 1 Diabetes Autoantigen Tyrosine Phosphatase IA-2: Potential for Mimicry with Rotavirus and Other Environmental Agents
    Margo C. Honeyman
    Natalie L. Stone
    Leonard C. Harrison
    Molecular Medicine, 1998, 4 : 231 - 239